Kestra Medical Technologies Receives $200M Loan Facility

Kestra Medical Technologies entered into a five-year term loan facility worth $200 million. The Washington-based wearable defibrillator maker entered into the loan facility with funds managed by Pharmakon Advisors, LP. The financing includes a $75 million tranche. Kestra used a portion of this to retire its existing $45 million term loan and pay fees and expenses. Read More